# ğŸ¯ INTEGRATION STATUS: VISUAL OVERVIEW

**Date**: October 31, 2024

---

## ğŸ“Š **SYSTEM ARCHITECTURE: WHAT'S WIRED vs. WHAT'S NOT**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                     FRONTEND LAYER                          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  CoPilot UI          â”‚        â”‚  Myeloma Digital     â”‚  â”‚
â”‚  â”‚  âŒ NOT WIRED        â”‚        â”‚  Twin Page           â”‚  â”‚
â”‚  â”‚                      â”‚        â”‚  âŒ NOT WIRED        â”‚  â”‚
â”‚  â”‚  - No treatment      â”‚        â”‚                      â”‚  â”‚
â”‚  â”‚    history input     â”‚        â”‚  - Components built  â”‚  â”‚
â”‚  â”‚  - No provenance     â”‚        â”‚  - Not imported      â”‚  â”‚
â”‚  â”‚    display           â”‚        â”‚  - Not used          â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  Ready Components (NOT IMPORTED ANYWHERE)            â”‚  â”‚
â”‚  â”‚  âœ… TreatmentHistoryForm.jsx       (353 lines)      â”‚  â”‚
â”‚  â”‚  âœ… TreatmentLineProvenance.jsx    (289 lines)      â”‚  â”‚
â”‚  â”‚  âœ… SAETreatmentLineChips.jsx      (154 lines)      â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â”‚
                            â”‚ API Calls
                            â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                     BACKEND LAYER                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  POST /api/efficacy/predict                          â”‚  â”‚
â”‚  â”‚  âœ… WIRED & WORKING                                  â”‚  â”‚
â”‚  â”‚                                                      â”‚  â”‚
â”‚  â”‚  Accepts:                                            â”‚  â”‚
â”‚  â”‚  {                                                   â”‚  â”‚
â”‚  â”‚    mutations: [...],                                 â”‚  â”‚
â”‚  â”‚    disease: "ovarian_cancer",                        â”‚  â”‚
â”‚  â”‚    model_id: "evo2_1b",                              â”‚  â”‚
â”‚  â”‚    treatment_history: {  âš ï¸  Optional, not used yet â”‚  â”‚
â”‚  â”‚      current_line: 2,                                â”‚  â”‚
â”‚  â”‚      prior_therapies: ["..."]                        â”‚  â”‚
â”‚  â”‚    }                                                 â”‚  â”‚
â”‚  â”‚  }                                                   â”‚  â”‚
â”‚  â”‚                                                      â”‚  â”‚
â”‚  â”‚  Returns:                                            â”‚  â”‚
â”‚  â”‚  {                                                   â”‚  â”‚
â”‚  â”‚    drugs: [                                          â”‚  â”‚
â”‚  â”‚      {                                               â”‚  â”‚
â”‚  â”‚        name: "olaparib",                             â”‚  â”‚
â”‚  â”‚        confidence: 0.72,  âœ… Modulated               â”‚  â”‚
â”‚  â”‚        treatment_line_provenance: {  âœ… Present     â”‚  â”‚
â”‚  â”‚          current_line: 2,                            â”‚  â”‚
â”‚  â”‚          cross_resistance_risk: 0.15,                â”‚  â”‚
â”‚  â”‚          confidence_penalty: -0.08                   â”‚  â”‚
â”‚  â”‚        }                                             â”‚  â”‚
â”‚  â”‚      }                                               â”‚  â”‚
â”‚  â”‚    ]                                                 â”‚  â”‚
â”‚  â”‚  }                                                   â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                            â”‚                                â”‚
â”‚                            â–¼                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  Efficacy Orchestrator                               â”‚  â”‚
â”‚  â”‚  âœ… FULLY INTEGRATED                                 â”‚  â”‚
â”‚  â”‚                                                      â”‚  â”‚
â”‚  â”‚  - Treatment line integration: âœ… ACTIVE             â”‚  â”‚
â”‚  â”‚  - Cross-resistance map: âœ… LOADED                   â”‚  â”‚
â”‚  â”‚  - Confidence modulation: âœ… WORKING                 â”‚  â”‚
â”‚  â”‚  - SAE features: âœ… COMPUTED                         â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                            â”‚                                â”‚
â”‚                            â–¼                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚  Drug Panels & Services                              â”‚  â”‚
â”‚  â”‚  âœ… PRODUCTION-READY                                 â”‚  â”‚
â”‚  â”‚                                                      â”‚  â”‚
â”‚  â”‚  - panel_config.py (475 lines, 10 drugs)            â”‚  â”‚
â”‚  â”‚  - cross_resistance_map.py (142 lines, 12 rules)    â”‚  â”‚
â”‚  â”‚  - treatment_line_integration.py (145 lines)        â”‚  â”‚
â”‚  â”‚  - 29/29 tests passing                               â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ”´ **THE GAP: FRONTEND NOT WIRED**

### **Current User Experience**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  USER OPENS MYELOMA DIGITAL TWIN PAGE               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Sees:                                              â”‚
â”‚  - Variant input fields                             â”‚
â”‚  - Model selector                                   â”‚
â”‚  - "Run Prediction" button                          â”‚
â”‚                                                     â”‚
â”‚  MISSING:                                           â”‚
â”‚  âŒ No treatment history input form                 â”‚
â”‚  âŒ No current line selector                        â”‚
â”‚  âŒ No prior therapies list                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼ User clicks "Run Prediction"
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Backend Receives:                                  â”‚
â”‚  {                                                  â”‚
â”‚    mutations: [...],                                â”‚
â”‚    disease: "multiple myeloma",                     â”‚
â”‚    model_id: "evo2_7b",                             â”‚
â”‚    treatment_history: null  âš ï¸  MISSING            â”‚
â”‚  }                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼ Backend processes with default (L1, no priors)
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Backend Returns:                                   â”‚
â”‚  {                                                  â”‚
â”‚    drugs: [                                         â”‚
â”‚      {                                              â”‚
â”‚        name: "olaparib",                            â”‚
â”‚        confidence: 0.80,  âš ï¸  NO PENALTY APPLIED   â”‚
â”‚        treatment_line_provenance: null  âš ï¸         â”‚
â”‚      }                                              â”‚
â”‚    ]                                                â”‚
â”‚  }                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  User Sees Results:                                 â”‚
â”‚  - Drug rankings                                    â”‚
â”‚  - Confidence scores (NOT ADJUSTED)                 â”‚
â”‚  - Evidence tiers                                   â”‚
â”‚                                                     â”‚
â”‚  MISSING:                                           â”‚
â”‚  âŒ No treatment line provenance panel              â”‚
â”‚  âŒ No SAE feature chips                            â”‚
â”‚  âŒ No cross-resistance warnings                    â”‚
â”‚  âŒ No confidence penalty explanation               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### **Desired User Experience (After Wiring)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  USER OPENS MYELOMA DIGITAL TWIN PAGE               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Sees:                                              â”‚
â”‚  âœ… Treatment History Section (NEW)                 â”‚
â”‚     - Current treatment line: [1] [2] [3] [4+]     â”‚
â”‚     - Prior therapies:                              â”‚
â”‚       â–¡ carboplatin+paclitaxel                      â”‚
â”‚       â–¡ olaparib                                    â”‚
â”‚       â–¡ doxorubicin_liposomal                       â”‚
â”‚                                                     â”‚
â”‚  - Variant input fields                             â”‚
â”‚  - Model selector                                   â”‚
â”‚  - "Run Prediction" button                          â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼ User selects: L2, prior=[carboplatin+paclitaxel]
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Backend Receives:                                  â”‚
â”‚  {                                                  â”‚
â”‚    mutations: [...],                                â”‚
â”‚    disease: "ovarian_cancer",                       â”‚
â”‚    model_id: "evo2_1b",                             â”‚
â”‚    treatment_history: {  âœ… PRESENT                 â”‚
â”‚      current_line: 2,                               â”‚
â”‚      prior_therapies: ["carboplatin+paclitaxel"]    â”‚
â”‚    }                                                â”‚
â”‚  }                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼ Backend applies cross-resistance logic
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  Backend Returns:                                   â”‚
â”‚  {                                                  â”‚
â”‚    drugs: [                                         â”‚
â”‚      {                                              â”‚
â”‚        name: "olaparib",                            â”‚
â”‚        confidence: 0.72,  âœ… PENALTY APPLIED        â”‚
â”‚        treatment_line_provenance: {  âœ… PRESENT    â”‚
â”‚          current_line: 2,                           â”‚
â”‚          cross_resistance_risk: 0.15,               â”‚
â”‚          line_appropriateness: 0.90,                â”‚
â”‚          confidence_penalty: -0.08,                 â”‚
â”‚          rationale: "DNA repair cross-resistance"   â”‚
â”‚        }                                            â”‚
â”‚      }                                              â”‚
â”‚    ]                                                â”‚
â”‚  }                                                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
              â”‚
              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  User Sees Results:                                 â”‚
â”‚  - Drug rankings                                    â”‚
â”‚  - Confidence scores (ADJUSTED: 0.80 â†’ 0.72)        â”‚
â”‚  - Evidence tiers                                   â”‚
â”‚                                                     â”‚
â”‚  âœ… NEW: Treatment Line Provenance Panel            â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”‚
â”‚     â”‚ Treatment Context                     â”‚      â”‚
â”‚     â”‚ Current Line: 2                       â”‚      â”‚
â”‚     â”‚ Prior Therapies: carboplatin+paclitax â”‚      â”‚
â”‚     â”‚ Cross-Resistance Risk: 15% (Low âš ï¸)   â”‚      â”‚
â”‚     â”‚ Line Appropriateness: 90% (Good âœ…)   â”‚      â”‚
â”‚     â”‚ Confidence Penalty: -8%               â”‚      â”‚
â”‚     â”‚ Rationale: DNA repair overlap between â”‚      â”‚
â”‚     â”‚ prior platinum and PARP inhibitor     â”‚      â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜      â”‚
â”‚                                                     â”‚
â”‚  âœ… NEW: SAE Feature Chips                          â”‚
â”‚     [Line Fit: 0.90 âœ…] [Cross-Res: 0.15 âš ï¸]      â”‚
â”‚     [Sequencing: 0.75]                              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ“Š **DRUG COVERAGE: CURRENT vs. TARGET**

### **Current State (Hereditary Pathway)**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  CURRENT DRUG PANELS (10 drugs, 2 diseases)        â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                     â”‚
â”‚  Ovarian Cancer (7 drugs)                          â”‚
â”‚  â”œâ”€ L1: carboplatin+paclitaxel                     â”‚
â”‚  â”œâ”€ L1: carboplatin+paclitaxel+bevacizumab         â”‚
â”‚  â”œâ”€ L1/L2: olaparib (maintenance/treatment)        â”‚
â”‚  â”œâ”€ L1/L2: niraparib (maintenance/treatment)       â”‚
â”‚  â”œâ”€ L2: gemcitabine+carboplatin                    â”‚
â”‚  â”œâ”€ L2: doxorubicin_liposomal                      â”‚
â”‚  â””â”€ L3: topotecan                                  â”‚
â”‚                                                     â”‚
â”‚  Breast HER2+ (3 drugs)                            â”‚
â”‚  â”œâ”€ L1: trastuzumab+pertuzumab+docetaxel           â”‚
â”‚  â”œâ”€ L2/L3: trastuzumab_deruxtecan (T-DXd)          â”‚
â”‚  â””â”€ L3: tucatinib+trastuzumab+capecitabine         â”‚
â”‚                                                     â”‚
â”‚  Cross-Resistance Rules: 12 entries                â”‚
â”‚  â”œâ”€ DNA repair pathway (5 rules)                   â”‚
â”‚  â”œâ”€ HER2 pathway (4 rules)                         â”‚
â”‚  â””â”€ Anthracycline class (3 rules)                  â”‚
â”‚                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### **Phase 1 Expansion (2-3 weeks) â†’ 50-70 drugs**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  TARGET PANELS (Phase 1: 6 diseases, 50-70 drugs)  â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                     â”‚
â”‚  1. Ovarian Cancer (7 drugs) âœ… COMPLETE           â”‚
â”‚  2. Breast HER2+ (3 drugs) âœ… COMPLETE             â”‚
â”‚                                                     â”‚
â”‚  3. Lung Cancer NSCLC (15-20 drugs) â³ NEXT        â”‚
â”‚     â”œâ”€ L1: osimertinib (EGFR+)                     â”‚
â”‚     â”œâ”€ L1: alectinib (ALK+)                        â”‚
â”‚     â”œâ”€ L1: crizotinib (ROS1+)                      â”‚
â”‚     â”œâ”€ L1: pembrolizumab (PD-L1 high)              â”‚
â”‚     â”œâ”€ L1: carboplatin+pemetrexed                  â”‚
â”‚     â””â”€ L2-L4: docetaxel, ramucirumab, etc.         â”‚
â”‚                                                     â”‚
â”‚  4. Colorectal Cancer (10-15 drugs) â³             â”‚
â”‚     â”œâ”€ L1: FOLFOX                                  â”‚
â”‚     â”œâ”€ L1: FOLFIRI                                 â”‚
â”‚     â”œâ”€ L1: cetuximab (RAS wild-type)               â”‚
â”‚     â”œâ”€ L2: regorafenib                             â”‚
â”‚     â””â”€ L2: trifluridine/tipiracil                  â”‚
â”‚                                                     â”‚
â”‚  5. Melanoma (8-10 drugs) â³                        â”‚
â”‚     â”œâ”€ L1: dabrafenib+trametinib (BRAF V600)       â”‚
â”‚     â”œâ”€ L1: nivolumab+ipilimumab                    â”‚
â”‚     â”œâ”€ L1: pembrolizumab                           â”‚
â”‚     â””â”€ L2: imatinib (c-KIT+)                       â”‚
â”‚                                                     â”‚
â”‚  6. Prostate Cancer (10-12 drugs) â³               â”‚
â”‚     â”œâ”€ L1: enzalutamide                            â”‚
â”‚     â”œâ”€ L1: abiraterone                             â”‚
â”‚     â”œâ”€ L1: docetaxel                               â”‚
â”‚     â”œâ”€ L2: cabazitaxel                             â”‚
â”‚     â””â”€ L2: radium-223                              â”‚
â”‚                                                     â”‚
â”‚  Cross-Resistance Rules: ~50-70 entries            â”‚
â”‚  â”œâ”€ EGFR pathway (lung)                            â”‚
â”‚  â”œâ”€ BRAF/MEK pathway (melanoma, CRC)               â”‚
â”‚  â”œâ”€ Androgen pathway (prostate)                    â”‚
â”‚  â”œâ”€ HER2 pathway (breast)                          â”‚
â”‚  â””â”€ DNA repair (ovarian, breast, prostate)         â”‚
â”‚                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### **Phase 2: Database Architecture (1-2 months) â†’ 200-300 drugs**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  DRUG DATABASE ARCHITECTURE                         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                     â”‚
â”‚  drug_database.json (or PostgreSQL table)          â”‚
â”‚  {                                                  â”‚
â”‚    "drugs": [                                       â”‚
â”‚      {                                              â”‚
â”‚        "id": "olaparib_001",                        â”‚
â”‚        "name": "olaparib",                          â”‚
â”‚        "class": "PARP_inhibitor",                   â”‚
â”‚        "mechanism": "DNA_repair_inhibition",        â”‚
â”‚        "approved_indications": [                    â”‚
â”‚          {                                          â”‚
â”‚            "disease": "ovarian_cancer",             â”‚
â”‚            "biomarker": "BRCA1/2_mutation",         â”‚
â”‚            "lines": [1, 2],                         â”‚
â”‚            "nccn_categories": {                     â”‚
â”‚              "1": "1",                              â”‚
â”‚              "2": "2A"                              â”‚
â”‚            }                                        â”‚
â”‚          },                                         â”‚
â”‚          {                                          â”‚
â”‚            "disease": "breast_cancer",              â”‚
â”‚            "biomarker": "BRCA1/2_germline",         â”‚
â”‚            "lines": [2, 3]                          â”‚
â”‚          }                                          â”‚
â”‚        ],                                           â”‚
â”‚        "cross_resistance": [                        â”‚
â”‚          "platinum_agents",                         â”‚
â”‚          "other_PARP_inhibitors"                    â”‚
â”‚        ],                                           â”‚
â”‚        "fda_approval_date": "2014-12-19",           â”‚
â”‚        "last_updated": "2024-06-15"                 â”‚
â”‚      }                                              â”‚
â”‚    ]                                                â”‚
â”‚  }                                                  â”‚
â”‚                                                     â”‚
â”‚  Auto-Population Logic:                            â”‚
â”‚  def get_panel(disease, mutations, line):          â”‚
â”‚      # 1. Query drugs by disease indication        â”‚
â”‚      # 2. Filter by biomarker match                â”‚
â”‚      # 3. Filter by line appropriateness           â”‚
â”‚      # 4. Apply cross-resistance rules             â”‚
â”‚      # 5. Rank by NCCN category                    â”‚
â”‚      return ranked_drugs                           â”‚
â”‚                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### **Phase 3: Guidelines Integration (3-6 months) â†’ 500+ drugs**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  REAL-TIME GUIDELINES INTEGRATION                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                     â”‚
â”‚  Data Sources:                                      â”‚
â”‚  â”œâ”€ NCCN Guidelines API (if available)             â”‚
â”‚  â”œâ”€ FDA Drug Approvals (realtime feed)             â”‚
â”‚  â”œâ”€ ClinicalTrials.gov (emerging therapies)        â”‚
â”‚  â”œâ”€ OncoKB (mutation-drug associations)            â”‚
â”‚  â””â”€ CIViC (clinical interpretations)               â”‚
â”‚                                                     â”‚
â”‚  Update Pipeline:                                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚ Daily Cron Job                            â”‚     â”‚
â”‚  â”‚ â”œâ”€ Fetch new FDA approvals                â”‚     â”‚
â”‚  â”‚ â”œâ”€ Check NCCN guideline updates           â”‚     â”‚
â”‚  â”‚ â”œâ”€ Sync OncoKB biomarker rules            â”‚     â”‚
â”‚  â”‚ â””â”€ Update drug database                   â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                     â”‚
â”‚  Result: Always up-to-date drug panels             â”‚
â”‚                                                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## ğŸ¬ **DEMO READINESS CHECKLIST**

### **Option 1: Full Demo (Requires Frontend Wiring) - 1-2 hours**

```
[ ] Frontend wiring complete
    [ ] Import TreatmentHistoryForm into MyelomaDigitalTwin.jsx
    [ ] Add treatment history state management
    [ ] Pass treatment_history to API payload
    [ ] Display TreatmentLineProvenance in results
    [ ] Display SAETreatmentLineChips in results

[ ] Test Ayesha's case end-to-end
    [ ] L1: No prior therapies â†’ confidence 0.80-0.85
    [ ] L2: Post-carboplatin+paclitaxel â†’ olaparib confidence 0.72 (-8%)
    [ ] L3: Post-olaparib â†’ topotecan confidence 0.68 (-12%)

[ ] Demo script prepared
    [ ] Setup instructions
    [ ] Act 1: First-line (2 min)
    [ ] Act 2: Progression to L2 (3 min)
    [ ] Act 3: Third-line challenge (2 min)
```

### **Option 2: Backend-Only Demo (Ready Now) - 5 minutes**

```
[âœ…] Backend API working
[âœ…] curl commands prepared
[âœ…] jq formatting for output
[âœ…] Before/after comparison ready

Demo Flow:
1. Show L1 curl â†’ confidence 0.80 (no penalty)
2. Show L2 curl â†’ confidence 0.72 (-8% penalty)
3. Show provenance JSON with rationale
4. Explain clinical impact
```

**Recommended**: Do Option 2 (backend demo) NOW, then wire frontend for Option 1.

---

## ğŸ’€ **COMMANDER'S ACTION ITEMS**

### **P0: Wire Frontend (1-2 hours)**
1. Open `oncology-coPilot/oncology-frontend/src/pages/MyelomaDigitalTwin.jsx`
2. Import treatment history components
3. Add state management
4. Wire to API payload
5. Display provenance in results
6. Test with Ayesha's case

### **P1: Integrate CoPilot (30 min)**
1. Open `oncology-coPilot/oncology-frontend/src/components/CoPilot/CoPilotLogic.jsx`
2. Add treatment_history to payload generation (line 120-125)
3. Display treatment line provenance in response cards
4. Add SAE chips to evidence panel

### **P2: Expand Drug Panels (1-2 weeks)**
1. Add Lung Cancer panel (15-20 drugs)
2. Add Colorectal Cancer panel (10-15 drugs)
3. Add Melanoma panel (8-10 drugs)
4. Add Prostate Cancer panel (10-12 drugs)
5. Build cross-resistance rules for new drugs

### **P3: Sporadic Pathway (3-4 hours)**
1. TumorContext schema
2. NGS parsers (Foundation, Tempus)
3. Germline vs. somatic gating
4. Frontend germline banner + NGS upload

---

**Status**: âœ… **HEREDITARY BACKEND COMPLETE, FRONTEND READY BUT NOT WIRED**

âš”ï¸ **STANDING BY FOR WIRING ORDERS** âš”ï¸


